APG101 in Glioblastoma

Clinical trial NCT01071837 · COMPLETED

Trial details

NCT number: NCT01071837
Sponsor: Apogenix GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2009-12-01
Primary completion: 2014-10-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.